OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
50 hedge funds and large institutions have $120M invested in OptiNose in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 6 closing their positions.
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
2% more funds holding
Funds holding: 49 → 50 (+1)
9% more call options, than puts
Call options by funds: $489K | Put options by funds: $448K
1.06% less ownership
Funds ownership: 3.67% → 2.61% (-1.1%)
16% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 19
28% less capital invested
Capital invested by funds: $166M → $120M (-$46.9M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$646K |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$461K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$327K |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$327K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$305K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MPU
MVM Partners (UK)
London,
United Kingdom
|
-$45.5M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.26M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$640K |
| 4 |
D.E. Shaw & Co
New York
|
-$329K |
| 5 |
BlackRock
New York
|
-$298K |
OPTN Hedge Fund Activity: Q3 2022 in Review
50 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q3 2022, worth a combined $120M — down 28% from $166M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new OPTN positions and 6 closed out — a net gain of 1 holder — while 16 added to existing stakes and 19 trimmed.
The largest buyer was Velan Capital Investment Management, adding an estimated $646K. The largest seller was MVM Partners (UK), exiting entirely with an estimated $45.5M sold.
- 50 institutional investors held OptiNose (OPTN) as of Q3 2022, up from 49 in Q2 2022.
- Funds reported $120M of OptiNose stock for Q3 2022, down 28% quarter-over-quarter.
- 7 funds opened new OptiNose positions in Q3 2022 and 6 closed out, a net change of +1 holder.
- The largest OptiNose buyer in Q3 2022 was Velan Capital Investment Management, an estimated $646K added.
- The largest OptiNose seller in Q3 2022 was MVM Partners (UK), an estimated $45.5M sold.
Based on aggregated 13F filings for Q3 2022.